To study other clinical factors that might affect the prognosis of GBM, we made univariate survival analysis that was stratified by each of the clinical factors (including gender, age, seizure, intracranial hypertension, tumor size, boundary, cystic change and necrosis, extent of resection, postsurgical radiotherapy or chemotherapy, and SAMSN1 expression) with Kaplan-Meier estimates in GBM. The gene discussed is SAMSN1; the disease is glioblastoma.